Your browser doesn't support javascript.
loading
Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease.
Li, He; Zhang, Yan-Jiao; Li, Mu-Peng; Hu, Xiao-Lei; Song, Pei-Yuan; Peng, Li-Ming; Ma, Qi-Lin; Tang, Jie; Zhang, Wei; Chen, Xiao-Ping.
Afiliação
  • Li H; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Zhang YJ; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
  • Li MP; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Hu XL; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
  • Song PY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Peng LM; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
  • Ma QL; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Tang J; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
  • Zhang W; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Chen XP; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
Front Pharmacol ; 9: 1039, 2018.
Article em En | MEDLINE | ID: mdl-30283338

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Suíça